Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease.
Kristl G ClaeysHani KushlafSyed RazaNoemi HummelSimon ShohetIan KeyzorAgnieszka KopiecRyan GrahamBrian FoxBenedikt SchoserPublished in: Orphanet journal of rare diseases (2024)
Our analysis shows that MCID depends on the chosen method and disease severity. The findings suggest that applying a single MCID to all patients can be misleading; consequently, a range of possible MCIDs should be considered. This may also be highly relevant for other neuromuscular diseases. This study provides a range of 6MWD MCIDs for LOPD, with lower MCIDs for more severe patients.